The EU chemicals strategy for sustainability: in support of the BfR position.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
09 2021
Historique:
received: 12 07 2021
accepted: 21 07 2021
pubmed: 8 8 2021
medline: 8 1 2022
entrez: 7 8 2021
Statut: ppublish

Résumé

The EU chemicals strategy for sustainability (CSS) asserts that both human health and the environment are presently threatened and that further regulation is necessary. In a recent Guest Editorial, members of the German competent authority for risk assessment, the BfR, raised concerns about the scientific justification for this strategy. The complexity and interdependence of the networks of regulation of chemical substances have ensured that public health and wellbeing in the EU have continuously improved. A continuous process of improvement in consumer protection is clearly desirable but any initiative directed towards this objective must be based on scientific knowledge. It must not confound risk with other factors in determining policy. This conclusion is fully supported in the present Commentary including the request to improve both, data collection and the time-consuming and bureaucratic procedures that delay the publication of regulations.

Identifiants

pubmed: 34363510
doi: 10.1007/s00204-021-03125-w
pii: 10.1007/s00204-021-03125-w
pmc: PMC8380226
doi:

Substances chimiques

Hazardous Substances 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

3133-3136

Informations de copyright

© 2021. The Author(s).

Références

European Commission (2019) Communication from the commission to the European Parliament, the council, the European economic and social committee and the committee of the regions: the European green deal. COM (2019) 640 final, date: 2019–12–11. 52019DC0640—EN—EUR-Lex, European Union
Herzler M, Marx-Stoelting P, Pirow R, Riebeling C, Luch A, Tralau T, Schwerdtle T, Hensel A (2021) The “EU chemical strategy for sustainability” questions regulatory toxicology as we know it: is it all rooted in sound scientific evidence? Arch Toxicol 95:2589–2601
doi: 10.1007/s00204-021-03091-3

Auteurs

Frank A Barile (FA)

College of Pharmacy and Health Sciences, St John's University, Queens, NY, USA.

Sir Colin Berry (SC)

Queen Mary University of London, London, UK.

Bas Blaauboer (B)

Division of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Alan Boobis (A)

National Heart and Lung Institute, Imperial College, London, UK.

Herrmann M Bolt (HM)

Leibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.

Christopher Borgert (C)

Applied Pharmacology and Toxicology, Inc., Gainesville, FL, USA.

Wolfgang Dekant (W)

Department of Toxicology, University of Würzburg, Würzburg, Germany.

Daniel Dietrich (D)

Faculty of Biology, University of Konstanz, Konstanz, Germany.

Jose L Domingo (JL)

Laboratory of Toxicology and Environmental Health, School of Medicine, IISPV, Universitat 'Rovira I Virgili', Reus, Spain.

Corrado L Galli (CL)

Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.

Gio Batta Gori (GB)

The Health Policy Center, Bethesda, MD, USA.

Helmut Greim (H)

Technical University of Munich, Munich, Germany. helmut.greim@mytum.de.

Jan G Hengstler (JG)

Leibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.

Pat Heslop-Harrison (P)

Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.

Sam Kacew (S)

McLaughlin Centre for Risk Assessment, University of Ottawa, Ottawa, Canada.

Hans Marquardt (H)

Toxicology, University of Hamburg, Hamburg, Germany.

Angela Mally (A)

Department of Toxicology, University of Würzburg, Würzburg, Germany.

Olavi Pelkonen (O)

Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland.

Kai Savolainen (K)

Nanosafety Research Centre, Finnish Institute of Occupational Health, Helsinki, Finland.

Emanuela Testai (E)

Environment and Health Department, Instituto Superiore Di Sanità, Rome, Italy.

Aristides Tsatsakis (A)

Medical School, University of Crete, Crete, Greece.

Nico P Vermeulen (NP)

Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH